New Stanford Medicine research shines light on animal-borne disease risk from drinking raw milk and how it relates to recent bird flu concerns.
Super-talented cellist Josh Roman opens up about how the condition caused him to doubt himself and his music. Now he’s back and sharing his story — at Stanford Medicine and well beyond.
FDA clears Stanford Medicine-spawned sepsis test, developed using machine learning, that leverages publicly available medical datasets from around the world.
Stanford Medicine researchers on the hunt for an elusive cardiac fibrosis drug were surprised when a malaria drug with ancient origins emerged as their top candidate.
Custom designing proteins — a breakthrough recognized by the latest Nobel Prize in chemistry — could yield treatments that stop the worst of COVID-19 before it begins.
As a new form of the viral disease spreads through Central Africa, prompting a global emergency declaration, Stanford Medicine infectious disease specialist Abraar Karan discusses how health systems can prepare and respond.
Gianna Nino-Tapias knows the challenges of migrant farmworkers better than most. Her mother continues to pick blueberries daily. She plans to use her medical degree to help integrate and advocate for better health care.
What does it mean that H5N1 bird flu, also known as highly pathogenic avian influenza A, is spreading among dairy cows? And how should U.S. health systems — and consumers of milk products — be responding?
Researchers who study long COVID say its debilitating symptoms are often misdiagnosed by clinicians and dismissed by employers or loved ones because so little is known about the new syndrome.
Nationwide, the percentage of health care visits for flulike symptoms ticked up above the baseline at the start of November and has remained elevated ever since, according to the Centers for Disease Control and Prevention.
The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.
The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.
Stanford Medicine researchers are designing vaccines that might protect people from not merely individual viral strains but broad ranges of them. The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.
Clinical fellow Alex Zimmet, MD, a member of Stanford Medicine’s antimicrobial stewardship team, discusses why antibiotic overuse is a problem and how you can help combat it.
Post-Nobel Prize announcement, we're spotlighting the science behind the mRNA-based COVID-19 vaccine and how it may impact medicine broadly.
Stanford Medicine infectious disease expert Anne Liu provides guidance on the RSV, flu and new COVID-19 vaccines this fall.
